3rd ALS Drug Development Summit 2024
Identify Transformative ALS Targets, Seek Translational Biomarkers and Propel More Clinical Approvals
Following monumental progress in 2023, the ALS treatment landscape is surging with novel innovation to navigate the complex, multifactorial nature of motor neuron degeneration and develop more truly transformative drugs for sporadic and familial ALS.
Time: 8:00 AM – 5:00 PM
Venue details: Hyatt Regency Boston, 1 Avenue de Lafayette, Boston, Massachusetts, 02111, United States
Prices:
Industry Pricing – Conference + Workshop Day: USD 3597.00,
Industry Pricing – Conference Only: USD 2599.00,
Service Provider Pricing – Conference + Workshop Day: USD 5197.00,
Service Provider Pricing – Conference Only: USD 3699.00
Email - info@hansonwade.com
Organizer - Hanson Wade